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SUMMARY
Spinal long-term potentiation (LTP) at C-fiber syn-
apses is hypothesized to underlie chronic pain.
However, a causal link between spinal LTP and
chronic pain is still lacking. Here, we report that
high-frequency stimulation (HFS; 100 Hz, 10 V) of
the mouse sciatic nerve reliably induces spinal
LTP without causing nerve injury. LTP-inducible
stimulation triggers chronic pain lasting for more
than 35 days and increases the number of calci-
tonin gene-related peptide (CGRP) terminals in the
spinal dorsal horn. The behavioral and morpholog-
ical changes can be prevented by blocking NMDA
receptors, ablating spinal microglia, or condition-
ally deleting microglial brain-derived neurotrophic
factor (BDNF). HFS-induced spinal LTP, microglial
activation, and upregulation of BDNF are inhibited
by antibodies against colony-stimulating factor 1
(CSF-1). Together, our results show that microglial
CSF1 and BDNF signaling are indispensable for
spinal LTP and chronic pain. The microglia-depen-
dent transition of synaptic potentiation to structural
alterations in pain pathways may underlie pain
chronicity.
INTRODUCTION
Chronic pain manifests as allodynia (decreased pain threshold),
hyperalgesia (increased pain response), and spontaneous pain.
Chronic pain affects about 20% of the population and results
in significant expenditure of healthcare resources (Yekkirala
et al., 2017). The main mechanisms underlying pathological
pain include hypersensitivity of nociceptors and persistent in-
creases in synaptic transmission within pain pathways (Liu and
Zhou, 2015). However, because conditions that induce chronic
pain are often associated with peripheral nerve degeneration
and local inflammation, it is not clear whether persistent synaptic
potentiation alone is sufficient to result in chronic pain.
Long-term potentiation (LTP) at C-fiber synapses in the spinal
dorsal horn (SDH) induced by high-frequency stimulation (HFS)
of the peripheral nerve is considered a synaptic model of patho-
logical pain (Liu and Zhou, 2015). Indeed, spinal LTP and nerve
injury-induced neuropathic pain share many common mecha-
nisms (Sandk€uhler and Gruber-Schoffnegger, 2012). In partic-
ular, both depend on N-methyl-D-aspartic acid (NMDA)
receptors (Liu and Sandk€uhler, 1995; Seltzer et al., 1991). In hu-
man volunteers, HFS at skin nociceptors has been shown to
produce mechanical allodynia and secondary hyperalgesia last-
ing for hours or even days in some cases (Pfau et al., 2011). In
rats, HFS (0.5 ms, 40 V, 10 trains of 2 s at 100 Hz with 10-s inter-
vals) at the sciatic nerve produces mechanical allodynia persist-
ing for at least 35 days but also damages the stimulated nerve
(Liang et al., 2010). To date, evidence of a causal link between
spinal LTP and chronic pain is still lacking.
In response to peripheral nerve injury or inflammation, micro-
glia, the principal immune cells, transform from a ramified to a
reactive state and release a repertoire of proinflammatory factors
that lead to pain hypersensitivity (Gu et al., 2016; Inoue and
Tsuda, 2018; Peng et al., 2016; Zhuo et al., 2011). Several
studies have shown that microglial activation is involved in
HFS-induced LTP and can even regulate synaptic strength inde-
pendent of neuronal activity (Clark et al., 2015; Gruber-Schoff-
negger et al., 2013; Kronschla¨ger et al., 2016; Zhong et al.,
2010). However, it is still unclear whether microglia participate
in spinal plasticity and pain hypersensitivity in the absence of
nerve injury.
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In the present study, we report that induction of spinal LTP at
C-fiber synapses by HFS does not injure the stimulated nerve
and leads to long-lasting mechanical allodynia and thermal hy-
peralgesia in mice. Using transgenic mice to either genetically
ablate microglia or specifically knock out microglial BDNF, we
determined that HFS at the sciatic nerve activates spinal micro-
glia via colony-stimulating factor 1 (CSF-1; namely, macrophage
CSF) signaling, which, in turn, releases BDNF from microglia to
increase calcitonin gene-related peptide (CGRP) terminals in
the SDH. Increases in CGRP terminals underlie long-lasting
pain hypersensitivity. These findings may explain how chronic
pain occurs in the absence of injury or disease, a state recently
classified as chronic primary pain by the World Health Organiza-
tion (Treede et al., 2015).
RESULTS
HFS Induces Chronic Pain without Detectable Injury of
the Stimulated Nerve
It has been proposed that spinal LTP at C-fiber synapses,
induced by HFS, may underlie chronic pain (Liu and Zhou,
2015). However, HFS may also induce chronic pain through
injury of the stimulated nerve (Liang et al., 2010). To explore
the causal relationship between spinal LTP and chronic pain, a
certain stimulation protocol that reliably induces LTP but does
not damage the stimulated nerve was first characterized. To
this end, we modulated the intensity of HFS and examined the
corresponding changes in spinal LTP induction and potential
nerve damage in mice. We found that HFS (100 pulses of
0.5 ms at 100 Hz, repeated 4 times at 10-s intervals) of the sciatic
nerve at both 10 V and 20 V, but not at 1 V, induced LTP of
C-fiber-evoked field postsynaptic excitatory potentials (fEPSPs)
(Figure 1A). To determine whether the stimulation protocols may
damage sensory neurons, we performed immunofluorescence
analysis to detect ATF3-positive nuclei, a well-established injury
marker, in L4 dorsal root ganglia (DRGs) after electrical stimula-
tion. ATF3 was significantly increased in mice receiving 20 V
HFS or spared nerve injury (SNI) surgery. However, neither
10 V nor 1 V of HFS caused ATF3 upregulation (Figures 1B
and 1C). Compared with the sham group, the latencies to fall
in the rotarod test, which evaluates motor function, was signifi-
cantly decreased in the 20 V HFS and SNI groups 7 days after
surgery but not in the 10 V HFS group (Figure 1D). Because sub-
tle damage to the nerve may attract pro-nociceptive immune
cells, we examined resident macrophages (stained by Iba1)
and neutrophils (by NIMP-R14) in 10 V HFS-stimulated sciatic
nerve 7 days after HFS. Compared with the sham group, there
was no significant change in Iba1 in stimulated sciatic nerves
(Figures 1E and 1F). NIMP-R14 neutrophils were not detected
in the sham and HFS groups. In contrast, these immune cells
were activated or infiltrated in the proximal sciatic nerve stump
or the connective tissue in SNI mice. Together, these results indi-
cate that 10 V HFS induces spinal LTP but does not result in
injury or inflammation in the stimulated nerve.
To determine whether HFS is capable of inducing chronic
pain, behavioral tests were performed in mice receiving HFS at
different intensities. Compared with the sham control, HFS at
20 V and 10 V, but not at 1 V, led to a reduction in pawwithdrawal
threshold (PWT) with mechanical stimuli (mechanical allodynia)
(Figure 1G) and in paw withdrawal latency (PWL) with thermal
stimuli (thermal hyperalgesia) (Figure 1H). The mechanical allo-
dynia and the thermal hyperalgesia induced by 10 V HFS lasted
for more than 21 days and around 14 days, respectively.
HFS may induce numerous changes in the stimulated nerve.
To rule out other changes that may contribute to chronic pain
hypersensitivity, we blocked action potential conduction in the
sciatic nerve with lidocaine (a sodium channel blocker, 2%,
50 mL) 15 min before HFS and found that mechanical allodynia
was completely blocked (Figure 1I). Spinal LTP is NMDA recep-
tor-dependent (Liu and Sandk€uhler, 1995). We found that intra-
thecal injection of the NMDA receptor antagonist D-AP5
(50 mg/mL, 5 mL, 253 nM) blocked spinal LTP without affecting
the C-fiber-evoked fEPSP baseline (Figure S1).This, in turn, pre-
vented HFS-induced allodynia (antagonist applied 30 min before
10 V HFS; Figure 1J). These results indicate that spinal LTP is
responsible for chronic pain hypersensitivity.
We repeated the above HFS experiments in rats, a species
also commonly used to test chronic pain. Interestingly, we found
Figure 1. HFS that Does Not Injure the Stimulated Sciatic Nerve Induces Spinal LTP and Chronic Pain Hypersensitivity in Mice
(A) Spinal LTP at C-fiber synapses was induced by HFS at 10 and 20 V but not at 1 V. The representative traces of C-fiber evoked fEPSPs were recorded before (i)
and 3 h (ii) after high-frequency stimulation (HFS) of the sciatic nerve at different intensities. The amplitude of C-fiber-evoked fEPSPs (red vertical line) was
determined automatically by the parameter extraction softwareWinLTP. Scale bars, 100ms (x) and 0.2mV (y). Summary data of the C-fiber responses expressed
as mean ± SEM plotted versus time are shown below (n = 6 mice/group). The arrow indicates the time point when HFS was delivered.
(B and C) Representative images (B) and statistical data (C) showing the expression of ATF3 in L4 DRG neurons 7 days after HFS at different intensities and 7 days
after spared nerve injury (SNI). Scale bar, 100 mm. n = 3-–4mice/group, 3 slices/mouse; ***p < 0.001 comparedwith the shamgroup, ###p < 0.001 versus 20 VHFS;
one-way ANOVA with Tukey’s test.
(D) The latencies to fall in the rotarod test in different groups 7 days after HFS at different intensities or SNI. n = 5–12 mice for each group, ***p < 0.001 compared
with the sham group, one-way ANOVA with Tukey’s test.
(E) Immunofluorescence of Iba1 (a marker of resident macrophages) and NIMP-R14 (a marker of neutrophils) in the stimulated sciatic nerve from different groups
7 days after HFS or SNI (n = 3 mice/group, 2–3 sections/mouse). Scale bar, 50 mm.
(F)Quantification of Iba1 expression in the sciatic nerve. ***p<0.001 comparedwith the shamgroup, ###p<0.001 versus 20VHFS;one-wayANOVAwithTukey’s test.
(G andH) HFS at 10 V and 20 V significantly decreased the 50%pawwithdrawal threshold (PWT) (G) to von Frey filaments and pawwithdrawal latency (PWL) (H) to
radiant thermal stimuli comparedwith the sham group or 1 VHFS (n = 12mice for the 10 VHFS group, n = 5–6mice for other groups; **p < 0.01, ***p < 0.001 versus
the sham group; two-way ANOVA with Fisher’s least significant difference [LSD] test).
(I) The decrease in mechanical thresholds induced by 10 V HFS was prevented by local application of 2% lidocaine (50 mL) at the stimulated sciatic nerve 15 min
before HFS (n = 5–7 mice/group). ###p < 0.001 versus the HFS group, two-way ANOVA with Fisher’s LSD’s test.
(J) Intrathecal injection of the NMDA receptor antagonist D-AP5 (50 mg/mL, 5 mL) but not vehicle (Vehi, PBS) 30 min before HFS abolished HFS-induced
mechanical hypersensitivity (n = 6–8 mice/group). ##p < 0.01, ###p < 0.001 versus the Vehi group; two-way ANOVA with Fisher’s LSD’s test.
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Figure 2. HFS Induces Long-Lasting Synaptic Potentiation andEnhances CGRPTerminals in the SDH in aNMDAReceptor-DependentManner
(A) Original representative traces of fEPSP and the input and output curves (stimulation intensity and C-fiber response) demonstrated that synaptic efficacy was
enhanced at 3–5 h or 7-–14 days after 10 V HFS (n = 12 mice in the sham and HFS 3–5 h groups, n = 8 mice in the HFS 7- to 14-day group; two-way ANOVA with
Tukey’s test). Scale bars, 50 ms (x) and 0.2 mV (y).
(legend continued on next page)
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that 20 V HFS at the rat sciatic nerve did not induce nerve injury
(no ATF3 upregulation) but was able to induce spinal LTP as well
as chronic pain hypersensitivity (Figures S2A–S2D). Histological
analyses using transmission electron microscopy (TEM) indi-
cated that, unlike SNI, electrical stimulation of the rat sciatic
nerve at 20 V HFS did not induce Wallerian degeneration of
myelinated nerve fibers and atrophy of axons in myelinated
and unmyelinated nerve fibers (Figures S2E and S2F). Taken
together, HFS-induced spinal LTP alone without nerve damage
is sufficient to trigger chronic pain hypersensitivity in mice and
rats. In further experiments, we investigated the cellular and
molecular mechanisms by which spinal LTP underlies chronic
allodynia using pharmacological and genetic tools and the
10 V HFS stimulation protocol.
10 V HFS Induces Long-Lasting Functional and
Structural Plasticity in the SDH
To address the cellular mechanism underlying the long-lasting
allodynia induced by short (4-s) electrical stimulation, we inves-
tigated the possibility of functional and structural plasticity in the
SDH after 10V HFS. To determine whether 10 V HFS induces
long-lasting LTP, we investigated the input and output curves
of C-fiber fEPSPs in mice receiving HFS 3–5 h or 7–14 days
before recordings and found that the curves shifted left in both
groups compared with sham mice (Figure 2A). The data indicate
that the spinal LTP induced by 10 V HFS in mice can persist for
more than 2 weeks.
To investigate the structural bases of the long-lasting synaptic
potentiation initiated by 10 V HFS, the CGRP+ peptidergic and
IB4+ nonpeptidergic C-fiber terminals in the dorsal horn were
examined following 10 V HFS. Western blots showed that CGRP
wassignificantly upregulated3daysafterHFSand that thechange
persisted formore than21days (Figure2B). Immunohistochemical
experimentsshowed thatCGRP+ terminals in theSDHweremainly
located in lamina I and outer lamina II (IIo) in sham control mice.
However, in mice treated with HFS, the CGRP+ terminals were
dramatically increased in both superficial and deep laminae of
the SDH (Figures 2C and 2D). Serial spinal coronal sections
showed that, 7 days after HFS, CGRP expression was markedly
upregulated in the ipsilateral L4–L6SDH,where sciatic nerve roots
carry sensory input. Furthermore, the upregulation of CGRP was
also extended to the ipsilateral L3 and S1 SDH (Figure S3).
Because the peptidergic terminals communicate with dorsal
horn neurons by both volume transmission (via release of bioac-
tive substances from varicosities) and by classical synaptic
transmission (Borroto-Escuela et al., 2015), we employed
pre-embedding immunoelectron microscopy (IEM) to test for
changes in CGRP+ varicosities and synapse numbers in the
SDH. We found that both synapse number and varicosity were
increased in lamina I–IV 7 days after HFS compared with the
sham group (Figures 2E and 2F). Importantly, we found that,
like LTP and chronic pain hypersensitivity, the increase in
CGRP afferents induced by HFS was also prevented by intra-
thecal injection of the NMDA receptor antagonist D-AP5 (Figures
2G and 2H). In contrast, no change in IB4 expression was
observed 7 days after HFS (Figures 2G and 2H).
Furthermore, immunostaining of the ipsilateral SDH showed
that the fluorescence intensity of synaptophysin (amarker of pre-
synaptic termini), GAP43 (a protein crucial for nerve fiber growth
and sprouting; Benowitz and Routtenberg, 1997), and substance
P (SP) were significantly increased 7 days after HFS compared
with the sham group. Their colocalization with CGRP was also
increased (Figures S4A–S4E). Therefore, presynaptic synapto-
physin, SP, and GAP43 levels are increased in CGRP+ terminals
after 10 V HFS. In addition, we found that the fluorescence inten-
sity of CGRP in the cell bodies of ipsilateral L4 DRG neurons
increases gradually from day 1 to day 7 after HFS (Figures S4F
and S4G). HFS induces a long-lasting increase in CGRP termi-
nals in the SDH, whichmay serve as a structural basis for chronic
pain hypersensitivity induced by HFS.
Microglia Are Required for HFS-Induced LTP and
Chronic Pain
Activation of microglia is important for both neuropathic pain
induced by nerve injury (Inoue and Tsuda, 2018) and for LTP
at C-fiber synapses (Clark et al., 2015). To determine the roles
of microglia in 10 V HFS-induced synaptic plasticity and pain
hypersensitivity, we first examined whether our stimulation pro-
tocol was able to activate spinal microglia. The expression of
Iba1 (a marker of microglia) in the SDH was significantly upre-
gulated at 3, 7, and 21 days but not acutely (5 h after HFS; Fig-
ure 3A). However, Iba1 staining also suggests that microglial
somata become enlarged between 5 h and 7 days after HFS
(Figure 3B). Further, the number of Iba1+ spinal microglia was
markedly increased 1 day after HFS (Figures 3B and 3C). In
contrast to SNI, which activated microglia in both the dorsal
and ventral horn, 10 V HFS did so only in the dorsal horn
(Figure S5A).
(B)Western blot assay illustrating the time course of changes in CGRP levels in the ipsilateral SDH following 10 VHFS (n = 3–4mice/group). **p < 0.01, ***p < 0.001
versus the sham group; one-way ANOVA with Fisher’s LSD test.
(C) Representative confocal images of whole ipsilateral SDH (left) andmagnified images (right) showing the distributions of CGRP+ terminals 7 days after 10 VHFS
or sham operation. The laminae of the SDH are indicated by white lines. Representative higher-magnification images from the dotted boxed regions in the larger
images show CGRP+ varicosities. Scale bars: 100 mm (left), 20 mm (right), 5 mm (right inset).
(D) Histograms showing the increased expression of CGRP+ terminals in different laminae of the ipsilateral SDH 3 or 7 days after HFS (n = 3–4 mice/group, 2–3
sections/mouse). **p < 0.01, ***p < 0.001 compared with the sham group; one-way ANOVA with Fisher’s LSD test.
(E and F) Electronmicrographs (E) and histograms (F) showing the CGRP-immunoreactive varicosities and synapses in the different laminae of the ipsilateral SDH
in the sham (n = 2 mice, 2–3 micrographs/lamina/mouse) and HFS groups (n = 3 mice, 2–3 micrographs/lamina/mouse). The black circles indicate CGRP+
varicosities and the white arrows CGRP+ synapses pointing from the presynaptic to the postsynaptic membrane. Scale bar, 200 nm. *p < 0.05, **p < 0.01,
***p < 0.001 compared with the sham group; one-way ANOVA with Tukey’s post hoc test.
(G andH) Representative images (G) and statistical data (H) showing the expression of CGRP (green) and IB4 (red) in the SDH 7 days after 10 VHFSwith or without
the NMDA antagonist D-AP5 (AP5). Scale bar, 50 mm (left). n = 3 mice/group, n = 3–4 images/mouse. ***p < 0.001 compared with the sham group, ###p < 0.001
versus the Vehi HFS group; one-way ANOVA with Tukey’s post hoc test.
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Figure 3. Microglia Ablation Blocks Spinal LTP, the Increase in CGRP Terminals, and Mechanical Allodynia Induced by HFS
(A) Western blots showing the time course of the Iba1 expression level after 10 V HFS (n = 3 mice/group). ***p < 0.001 versus the sham group, one-way ANOVA
with Fisher’s LSD test.
(legend continued on next page)
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To determine the causal link between microglial activation,
spinal plasticity, and chronic pain hypersensitivity, we performed
experiments with CX3CR1CreER/+:R26iDTR/+ mice, in which
CX3CR1 cells express the diphtheria toxin (DT) receptor (Par-
khurst et al., 2013; Peng et al., 2016). DT was applied 3 weeks
after the last injection of tamoxifen (TM) to selectively ablate
microglia in the CNS but not peripheral macrophages because
of their fast turnover. We found that microglia were largely abla-
ted at 3 days after DT injection in CX3CR1CreER/+:R26iDTR/+
mice. Afterward, microglia fully repopulated within 3 weeks (Fig-
ures 3D and 3E). Interestingly, HFS at 10 V was unable to induce
spinal LTP 3 days after DT injection, whereas LTP could be
induced when microglia were repopulated 21 days after DT
treatment (Figure 3F). These results strongly indicate that spinal
microglia are required for HFS-induced LTP.
If microglial depletion abolishes LTP, then we expect that
HFS-induced, long-lasting functional and structural plasticity
would be reduced. Indeed, in mice receiving HFS 3 days after
DT injection, fEPSP input and output curves, measured
7–14 days after HFS, were not different from sham mice. In
non-DT control mice, HFS induced a leftward shift of the curve
(Figure 3G). Consistently, the increase in CGRP terminals
induced by HFS was also substantially attenuated in micro-
glia-depleted mice compared with control mice (Figures 3H
and 3I). Finally, we found that HFS-induced mechanical allody-
nia was significantly reduced in mice receiving a DT injection
3 days before HFS compared with either control mice or mice
receiving a DT injection 21 days before HFS (Figure 4J). These
results indicate that the development of mechanical allodynia is
dependent on spinal microglia. Spinal LTP in mice was induced
within 20 min after HFS and stabilized at around 1 (Figure 1A
and 3F). We observed that mechanical hypersensitivity devel-
oped swiftly and fully 30 min after HFS (Figure 4J). To test
whether microglia are also involved in the maintenance of
mechanical allodynia, DT was injected 7 days and 9 days after
HFS. We found that deletion of microglia was unable to reverse
HFS-induced mechanical allodynia (Figures S5B and S5C).
Together, these results suggest that microglia are indispens-
able for induction but not for maintenance of HFS-induced
chronic pain hypersensitivity.
Microglial BDNF Is Essential for HFS-Induced LTP and
Chronic Pain
BDNF has been implicated in spinal LTP and neuropathic pain
(Coull et al., 2005; Zhou et al., 2011). Therefore, we examined
the role of microglial BDNF in synaptic plasticity and chronic
pain induced by HFS using CX3CR1CreER/+:BDNFflox/flox male
mice, in which BDNF can be specifically deleted from microglia
by TM injection. To ensure deletion of microglial BDNF, the ex-
periments were performed around 3 weeks after TM injection
(Figure 4A). We found that HFS induced LTP and increased
CGRP+ terminals in the SDH in control mice (BDNF+/+) but not
in mice with microglial BDNF deletion (BDNF/; Figures
4A–4D). Deletion of BDNF from microglia attenuated HFS-
induced mechanical allodynia in both male and female mice,
whereas the samemanipulation prevented SNI-induced pain hy-
persensitivity only in male mice (Figure 4E), which is consistent
with a previous work (Sorge et al., 2015). These results indicate
that microglial BDNF is required for HFS-induced functional
and structural synaptic plasticity in the SDH, contributing to
chronic pain.
To confirm the roles of BDNF for HFS-induced cellular and
behavioral changes, BDNF (20 ng/mL, 5 mL) was injected intrathe-
cally into wild-type mice. We found that BDNF directly caused
mechanical allodynia that lasted for more than 10 days (Fig-
ure S6A). Consistent with the role of BDNF in promoting the
sprouting of CGRP primary afferents (Orita et al., 2011; Song
et al., 2008), immunostaining and western blot revealed that
CGRP expression in the SDH was significantly increased
3 days after BDNF injection (Figures S6B and S6C), whereas
CGRP in DRG neurons was not changed (data not shown). To
further investigate the effect of BDNF on CGRP terminals and
to explore the underlying mechanisms, we performed experi-
ments in cultured DRG neurons. Compared with the control cul-
tures, application of BDNF (50 ng/mL) for 1 day markedly
increased CGRP neurite length. This effect of BDNF was abol-
ished by both the tropomyosin receptor kinase B (TrkB) antago-
nist ANA-12 (10 mM) and the cAMP-response element binding
protein (CREB) inhibitor 666-15 (0.5 mM) (Figures S6D and
S6E). These results suggest that BDNF promotes the increase
in CGRP terminals via the BDNF/TrkB/CREB signaling pathway.
(B and C) Representative images of Iba1 immunostaining (B) and histogram (C) showing that the number of Iba1+ microglia were increased in the ipsilateral SDH
1, 3, and 7 days after 10 V HFS and 7 days after SNI. Iba1+ cells were increased only in the ipsilateral but not in the contralateral SDH 7 days after HFS (7dI and
7dC). Scale bar, 50 mm. n = 3mice/group, 2–3 sections/mouse. ***p < 0.001, ****p < 0.0001 versus the sham group, ###p < 0.001 versus the HFS 7-day group; one-
way ANOVA with Fisher’s LSD test.
(D) Experiment designs for control or microglial ablation (MG abl) 3 or 21 days after Vehi (corn oil) diphtheria toxin treatment in CX3CR1CreER/+:R26iDTR/+mice. DT,
diphtheria toxin; TM, tamoxifen; Pain Beha, pain behavior test; EP, electrophysiology. In the DT 3-dayHFS or DT 21-day HFS group, DTwas injected 3weeks after
TM, and HFS was delivered 3 or 21 days after last application of DT. In the control group, Vehi but not DT was injected following TM injection.
(E) Immunofluorescent staining showing that microglia were largely depleted 3 days after DT treatment (DT 3d) and then fully repopulated within 21 days after DT
treatment (DT 21d) in CX3CR1CreER/+:R26iDTR/+ mice. Boxed areas are magnified in the right panel. Scale bars, 100 mm (left) and 25 mm (right).
(F) HFS was able to induce LTP 21 days but not 3 days after DT injection (n = 12 mice for the DT 3-day group, n = 6–7 mice for the other groups; two-way ANOVA
with Tukey’s test). Representative traces of evoked C-fiber fEPSP are shown above before (i, gray line) and 3 h after 10 V HFS (ii, colored line). Scale bars, 100ms
(x) and 0.15 mV (y). The arrow indicates the time point when HFS was delivered.
(G) Input and output curves of fEPSPsmeasured 7 days after HFS inmice treated with DT (for MG abl) and with Vehi (n = 5mice for the sham group, n = 5 or 7mice
for the MG abl groups).
(H and I) Representative images (H) and statistical analysis (I) showed the increase in CGRP+ terminals induced by HFS was substantially attenuated in microglia
ablation mice (n = 3 mice/group, 2–3 sections/mouse). Scale bar, 20 mm. ***p < 0.001 versus the control sham group; #p < 0.05, ##p < 0.01 versus the control HFS
3-day or 7-day group; one-way ANOVA with Fisher’s LSD test.
(J) HFS inducedmechanical allodynia inmicewithmicroglia full repopulation (DT 21 days) but not inmicewithmicroglia ablation (DT 3 days). n = 12mice in theMG
abl DT 3-day group, n = 8 mice for other groups. **p < 0.01, ***p < 0.001 versus control HFS; two-way ANOVA with Fisher’s LSD test.
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CSF1 Signaling in Microglial Activation, LTP Induction,
and Chronic Pain
It is unclear how HFS could activate spinal microglia in the sciatic
nerve. A recent study showed that peripheral nerve injury induces
de novo expression of CSF1 in injured DRG neurons. CSF1 acti-
vates microglia by binding to CSF1 receptors (CSF1Rs) that are
exclusively expressed in microglia in the SDH (Guan et al.,
2016). Therefore, we tested whether CSF1 signaling might also
participate in 10 V HFS-induced microglial activation, spinal
LTP, and chronic pain. To do this, we first examined the expres-
sion of CSF1 in DRGs and the dorsal horn after HFS. In DRG neu-
rons, we found that CSF1 was expressed at a very low level in
sham mice and upregulated gradually from 1 day to 7 days after
10 V HFS (Figures 5A and 5B). CSF1 expression induced by HFS
was lower than that induced by SNI (Figure 5B). In SNI rats, CSF1
was expressed not only in injured DRG neurons (Figure 5A,
ATF3+, arrowheads) but also in uninjured neurons (ATF3, ar-
rows), which is consistent with previous work (Guan et al.,
2016). Interestingly, we found that, in the SDH,CSF1was only co-
localized with CGRP but not with IB4 (Figure 5C). These results
Figure 4. Ablation of Microglial BDNF Prevented LTP Induction, the Increase in CGRP Terminals, and Mechanical Allodynia Induced by HFS
(A) Schematic overview of experiments with BDNF/, CX3CR1CreER/+:BDNFflox/flox mice, in which BDNF can be specifically deleted frommicroglia by TM injection.
(B) 10VHFS induced spinal LTP in BDNF+/+mice but not inmicewithmicroglial BDNF deletion (BDNF/). n = 6–7mice/group. Examples of C-fiber field potentials
are shown above (i, gray lines) and 3 h after 10 V HFS (ii, color lines). Scale bars, 100 ms (x) and 0.2 mV (y). The arrow indicates the time point when conditional
stimulation was delivered.
(C and D) Representative images (C) and summary data (D) showing that HFS-induced CGRP upregulation was inhibited by microglial BDNF ablation (n =
3–4 mice/group, 3–4 sections/mouse). ***p < 0.001 versus the BDNF+/+ sham group, ###p < 0.001 versus the BDNF+/+ HFS group; one-way ANOVA with Fisher’s
LSD test. Scale bars, 100 mm (top) and 20 mm (bottom).
(E) Unlike in the SNI model, HFS-induced mechanical allodynia was significantly reversed in male and female mice deficient of microglial BDNF compared with
control mice. ***p < 0.001 versus the female BDNF+/+ HFS or SNI group, two-way ANOVA with Fisher’s LSD test.
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Figure 5. HFS Upregulates CSF1 in CGRP Terminals and CSF1 Receptors in Microglia, Leading to Spinal LTP and Pain Hypersensitivity
(A and B) Representative images (A) and statistical analysis (B) showing the expression of CSF1 in the ipsilateral L4 DRG from 1 to 7 days after HFS and 7 days
after SNI. The triple staining images show colocalization of CSF1, CGRP, and ATF3. The arrowheads indicate that injured DRG neurons (ATF3+) that strongly
express CSF1 do not express CGRP. The arrows indicate uninjured neurons (ATF3) that weakly express CSF1 express CGRP following HFS or SNI. Scale bar,
50 mm. n = 3 mice/group, n = 2–3 images/mouse; *p < 0.05, ***p < 0.001 versus the sham group; ###p < 0.001 compared with the HFS 7-day group; one-way
ANOVA with Tukey’s post hoc test.
(legend continued on next page)
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indicate that HFS upregulates CSF1 in DRG neurons and in
CGRP+ terminals in the SDH. Similarly, CSF1 mRNA progres-
sively increased in ipsilateral L4–L5 DRGs from 1 day to 7 days
after HFS (Figure 5D). Compared with HFS, SNI resulted in
more significant enhancement in CSF1 mRNA 2 days after nerve
injury. Moreover, in cultured DRG neurons, 40 mM KCl, which
causes dramatic DRG neuron depolarization, significantly
increased CSF1 in culture medium (Figure 5E), indicating that
DRG neurons release CSF1 upon activation. Furthermore, immu-
nofluorescence showed that HFS also significantly upregulated
CSF1R in Iba1+ microglia from 1 to 3 days after HFS (Figures
5F and 5G). Western blots revealed that both CSF1R and Iba1
were upregulated by HFS and that the changes were prevented
by a single intrathecal injection of anti-CSF1 (40 ng/mL, 5 ml)
30 min before HFS (Figure 5H). This result indicates that CSF1
signaling is necessary for HFS-induced microglial activation. To
determine the role of CSF1 signaling in spinal LTP, anti-CSF1
(40 ng/mL, 20 mL) was applied to the dorsal surface of the spinal
cord 30 min before HFS. We found that anti-CSF1 did not affect
basal transmission but blocked late-phase spinal LTP. Specif-
ically, HFS-induced potentiation only lasted for approximately
1 h and then gradually returned to baseline, whereas application
of immunoglobulin G (IgG) affected neither basal transmission nor
LTP induction (Figure 5I). Consistently, we found a single intra-
thecal injection of CSF1 (6 ng/mL, 5 mL, daily for 3 days) induces
mechanical allodynia lasting for around a week (Figure S7A)
and upregulates CSF1R in activated spinal microglia (Figures
S7B–S7E). This indicates that CSF1 is also sufficient to activate
spinal microglia. Additionally, we found that the single intrathecal
anti-CSF1 injection also substantially attenuated HFS-induced
chronic allodynia (Figure 5J). These results suggest that HFS-
induced CSF1 upregulation in DRGs and CGRP-afferent termi-
nals is important for chronic pain.
CSF1 Signaling-Dependent Microglial BDNF in
HFS-Induced Chronic Pain
We have demonstrated that both CSF1 signaling and microglial
BDNF are required for HFS-induced functional and structural syn-
aptic plasticity as well as pain hypersensitivity. However, it is still
unknown whether CSF1 signaling and microglial BDNF are inde-
pendently engaged in HFS-induced chronic pain. To determine
whether there is a relationship between increased CSF1 signaling
and upregulation of BDNF andCGRP, we applied anti-CSF1 anti-
body (40 ng/mL, 5 mL) intrathecally 30 min before HFS. We then
examined BDNF and CGRP expression 3 days later. We found
that anti-CSF1 treatment reduced both BDNF andCGRP upregu-
lation otherwise induced by HFS (Figure 6A). To verify the effects
of CSF1 on microglial activation and to investigate the underlying
mechanisms, we performed experiments with cultured spinal
cord slices. Treatment with CSF1 (1 mg/mL) for 6 h markedly up-
regulated microglial markers (CD11b and Iba1) as well as CSF1R
expression. These effects were dose-dependently suppressed
by the selective p38 mitogen-activated protein kinase (MAPK)
inhibitor SB203580 (1 mMor 10 mM, added 1 h prior to CSF1) (Fig-
ures 6B–6D). Western blots showed that CSF1 application upre-
gulated CSF1R, p-p38 MAPK, and BDNF. These increases were
significantly blocked by SB203580 (Figure 6E). CSF1 also
increased BDNF in culture medium, which could also be attenu-
ated by SB203580 (Figure 6F). Because p38 is exclusively ex-
pressed in microglia in the SDH and its activation is critical for mi-
croglial activation (Ji and Suter, 2007), these in vitro experiments
indicate that CSF1 is sufficient for microglial activation and BDNF
release, whereas BDNF release depends onmicroglial activation.
Based on the above results, we hypothesized that activation of
CSF1 signaling byHFS leads tomicroglial activation and that sub-
sequent microglial BDNF release is critical for the increase in
CGRP terminals and associated chronic pain behaviors. To
directly test this hypothesis, we examined the effect of CSF1 on
CGRP expression in the presence or absence of microglial
BDNF. We found that intrathecal injection of CSF1 (20 ng/mL,
5 mL) increased CGRP expression only in control mice (BDNF+/+)
but not in CX3CR1CreER/+:BDNFflox/flox mice 21 days after TM in-
jection (BDNF/), when BDNF was selectively deleted in micro-
glia (Figure 6G). CSF1-induced mechanical allodynia was largely
attenuated in mice deficient of microglial BDNF compared with
control mice (Figure 6H). Therefore, microglial-specific BDNF is
required for CSF1-induced CGRP upregulation and chronic pain.
DISCUSSION
LTP in the hippocampus is considered a biological substrate
for some forms of memory (Bliss and Collingridge, 1993). To
(C) Triple staining showing that CSF1 in SDH was co-localized with CGRP but not with IB4 3 days after HFS. Scale bar, 20 mm.
(D) qRT-PCR analysis of CSF1 mRNA in ipsilateral L4–L5 DRGs from different groups (n = 7–12 mice/group). Values are presented as means ± SEM. *p < 0.05,
**p < 0.01, ****p < 0.00001 versus the sham group; ###p < 0.001 compared with the HFS 7-day group; one-way ANOVA with Fisher’s LSD test.
(E) Western blot and statistical analysis showing that treatment of cultured DRG neurons with 40 mM KCl for 24 h increased CSF1 in culture medium. n = 6
samples/group, **p < 0.01 versus Vehi group, unpaired Student’s t test.
(F and G) Representative images (F) and statistical analysis (G) showing that CSF1R in microglia was upregulated in the ipsilateral dorsal horn 1 and 3 days after
HFS (n = 3 mice/group, 2–3 sections/mouse). Scale bar, 50 mm. ***p < 0.001 compared with the sham group, ###p < 0.001 compared with the HFS 7-day group;
one-way ANOVA with Tukey’s post hoc test.
(H) Western blots illustrating the increased expression of CSF1R and Iba1 protein levels 3 days after 10 V HFS and that the changes were blocked by intrathecal
injection of CSF1-neutralizing antibody (anti-CSF1, 40 ng/mL, 5 mL) 30 min before HFS (n = 3–4 mice/group). **p < 0.01, ***p < 0.001 versus the sham group;
###p < 0.001 versus the control HFS group; one-way ANOVA with Fisher’s LSD test.
(I) Local application of anti-CSF1 (40 ng/mL, 20 mL) onto the dorsal surface of the spinal cord at recording segments 30 min before HFS did not affect the baseline
of C-fiber responses but blocked the late phase of the spinal LTP (n = 5–6 mice/group). Original traces of C-fiber fEPSPs from different groups, recorded at
baseline (i), 30min before (ii), and 3 h (iii) after HFS, are shown at the top. Scale bars, 100ms (x) and 0.2mV (y). The arrow indicates the time point when conditional
stimulation was delivered.
(J) Intrathecal injection of anti-CSF1 antibody 30min before HFS prevented the development of mechanical hypersensitivity (n = 6mice/group, ***p < 0.001 versus
the Vehi group, two-way ANOVA with Fisher’s LSD test).
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date, however, a definitive demonstration indicating that
memory and LTP share the same cellular and molecular
mechanisms and that induction of LTP will result in some
form of memory is still lacking (Lynch, 2004). This is difficult
to achieve, largely because of the complexity in synaptic con-
nections and functions of the hippocampus. On the other
hand, spinal LTP at C-fiber (pain fiber) synapses (Liu and
Sandk€uhler, 1995) is believed to be a pain memory that may
underlie some forms of chronic pain (Liu and Zhou, 2015).
The present work provides evidence supporting the hypothe-
sis that induction of LTP at synapses between afferent
C-fibers and dorsal horn neurons by 10 V HFS is associated
with mechanical allodynia lasting for 50 days in rats (Fig-
ure S2B) and more than 35 days in mice (Figure 4E) as well
as thermal hyperalgesia for around 14 days (Figure 1H). A mi-
croglial BDNF-dependent increase in (or sprouting of) CGRP
terminals, which is found in a variety of chronic pain condi-
tions (Christensen and Hulsebosch, 1997; Xu et al., 2017;
Zheng et al., 2008), serves as a structural basis of the chronic
pain. Our finding is also clinically important because chronic
pain, unlike acute pain, rarely has an identifiable temporal
and causal relationship with injury or disease in the body.
Chronic pain with unknown etiology was recently classified
as chronic primary pain (Treede et al., 2015), with the under-
lying mechanism still poorly understood. Spinal LTP at C-fiber
synapses can be induced in many ways, including periph-
eral nerve injury (Zhang et al., 2004), activation of pre-
synaptic terminals by electrical stimulation of afferent C-fibers
(Liu and Sandk€uhler, 1995), or direct activation of glial cells
by local application of BDNF (Zhou et al., 2008), fractalkine
(Clark et al., 2015) or ATP receptor agonists (Kronschla¨ger
et al., 2016) without direct activation of the presynaptic
component. At present, it is generally believed that chronic
pain is produced by nerve injury (neuropathic pain) and/or
inflammation (inflammatory pain) (Yekkirala et al., 2017).
Here we show that HFS-induced chronic pain in naive mice
is neither associated with nerve injury nor inflammation near
the stimulated nerve (Figures 1B–1F). Therefore, we exposed
a form of chronic pain that is produced by activation of spinal
microglia through intensive peripheral nerve stimuli (Figure 7).
This mechanism may be an important insight into explaining
chronic pain without a clinically obvious cause.
Action Potential Discharge in Nociceptive Afferents
Evoked by HFS Underlie Chronic Pain
Sturge (1883) demonstrated that peripheral injury triggers a
change in CNS excitability so that normal inputs evoke exagger-
ated responses as part of pain hypersensitivity. Consistent with
this notion, nerve injury has been shown to induce a transient ac-
tion potential discharge in afferent A- and C-fibers within the first
seconds following injury (Liu et al., 2000). This phenomenon,
called injury discharge, is believed to trigger chronic pain. To
date, however, whether the injury discharge alone is sufficient
to generate chronic pain is still unknown because peripheral
nerve injury also causes hypersensitivity of the afferent neurons.
Our previous work shows that injury of the sciatic nerve in-
duces LTP at C-fiber synapses within minutes and that the effect
is completely prevented by blocking action potential conduction
with lidocaine (Zhang et al., 2004), indicating that the injury
discharge is sufficient to induce spinal LTP. In the current study,
we showed that HFS at the sciatic nerve triggered long-lasting
pain hypersensitivity in mice by inducing spinal LTP without
any observable nerve injury. Temporally, HFS induced spinal
LTP within a few minutes and pain hypersensitivity in about
30 min. Inhibition of LTP by local application of lidocaine to the
sciatic nerve or by intrathecal injection of an NMDA receptor
antagonist prevented chronic pain (Figures 1I and 1J; Figure S1).
However, HFS at A-fibers neither induced LTP nor chronic pain.
Activation of spinal NMDA receptors through HFS of nociceptive
afferents is sufficient to induce chronic pain hypersensitivity.
These effects are not associated with any other changes in the
periphery that might be produced by HFS. Interestingly, we
have shown that action potential discharges in primary afferent
C-fibers by HFS are sufficient to activate spinal microglia.
Consequently, HFS may potentially induce neurogenic neuroin-
flammation in the spinal cord as the root cause of chronic pain.
The Roles of Peptidergic C-fiber Terminals in Initiation
and Maintenance of HFS-Induced Chronic Pain
Hypersensitivity
Peptidergic C-fiber terminals express and release bioactive sub-
stances, including glutamate, CGRP, SP, BDNF (Lever et al.,
2001), ATP (Kronschla¨ger et al., 2016), fractalkine (Clark et al.,
2015), and CASP6 (Berta et al., 2014). These released signaling
molecules play a role in spinal LTP and pain hypersensitivity by
Figure 6. Microglial BDNF Is Required for an CSF1-Induced Increase in CGRP Terminals and Pain Hypersensitivity
(A) HFS upregulated BDNF and CGRP levels in the SDH, and the effects were prevented by intrathecal injection of anti-CSF1 (40.0 ng/mL) 30 min before HFS
(n = 3–6 mice/group). ***p < 0.001 versus the control sham group; ##p < 0.01, ###p < 0.001 versus the control HFS group; $p < 0.05 versus the anti-CSF1 sham
group; one-way ANOVA with Fisher’s LSD test.
(B and C) In cultured spinal cord slices, CSF1 (1 mg/mL) markedly upregulated microglial markers (CD11b and Iba1, B) and CSF1R (C), and the effects were dose-
dependently suppressed by the p38 MAPK inhibitor SB203580 (10 mM) applied 1 h prior to CSF1. Scale bar, 100 mm.
(D) Pooled results showing the difference in Iba1 or CSF1R expression in different groups. n = 4–5 samples/group; *p < 0.05, ***p < 0.001 versus the control group;
###p < 0.001 versus the CSF1 group; one-way ANOVA with Tukey’s post hoc test.
(E and F) In culture spinal cord slices, treatment with CSF1 for 6 h upregulated CSF1R, phospho-p38 MAPK (p-p38), and BDNF (E) as well as increased BDNF in
culture medium (F). Pretreatment with the p38 inhibitor SB203580 (10 mM) abolished the effects of CSF1. n = 3–5 samples/group; **p < 0.01, ***p < 0.001 versus
the control group; ##p < 0.01 versus the CSF1 group; one-way ANOVA with Tukey’s post hoc test.
(G) Intrathecal CSF1 upregulated CGRP expression in BDNF+/+ mice but not in mice deficient of microglial BDNF (BDNF/), as measured 3 days after in-
jection (n = 3–6 mice/group). ***p < 0.001 versus the BDNF+/+PBS group, ###p < 0.001 versus the BDNF+/+ CSF1 group; one-way ANOVA with Fisher’s
LSD test.
(H) Mechanical allodynia induced by intrathecal CSF1 was significantly attenuated in microglial BDNF deletion mice compared with control mice (n =
5–6 mice/group, ###p < 0.001 versus the BDNF+/+ CSF1 group, two-way ANOVA with Fisher’s LSD test).
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volume transmission as well as by classical synaptic transmis-
sion (Borroto-Escuela et al., 2015). For example, both NK1 and
NK2 SP receptors are required for spinal LTP induction (Liu
and Sandk€uhler, 1997). Spinal application of BDNF directly in-
duces late-phase spinal LTP andmechanical allodynia by activa-
tion of microglia (Zhou et al., 2011). Human studies suggest that
activation of peptidergic cutaneous afferents is responsible for
HFS-induced mechanical allodynia (Pfau et al., 2011). Together,
activation of peptidergic C-fibers is critical for induction of spinal
LTP at C-fiber synapses.
CGRP has been identified as an important molecule in spinal
nociceptive processing and in migraine headache (Edvinsson
et al., 2018). Increases in CGRP afferents in SDH has been re-
ported in a variety of chronic pain conditions, such as vincris-
tine-induced neuropathy (Xu et al., 2017), sciatic nerve crush
or transection (Zheng et al., 2008), and spinal cord hemisection
(Christensen and Hulsebosch, 1997). In the present work, we
showed that CGRP terminals, the number of CGRP+ varicosities,
and the number of CGRP+ synapses increased significantly
in the dorsal horn following HFS (Figures 2C–2F). Importantly,
in CGRP+ terminals, synaptophysin, SP, and GAP43 were signif-
icantly increased after HFS (Figure S4). These data suggest
that the increase in CGRP+ terminals results from axon
sprouting. Therefore, we presumed that the increase in CGRP
terminals may be critical for the transition from acute pain to
chronic pain.
NMDA receptors are critical for the induction of spinal LTP (Liu
and Sandk€uhler, 1995). In the present work, we demonstrated
that blocking NMDA receptors with D-AP5 suppressed HFS-
induced CGRP increases (Figures 2G and 2H), which is consis-
tent with previous studies (Csa´ti et al., 2015; Wong et al.,
2014). Because synaptic functional plasticity leads to structural
plasticity, the effect of the NMDA receptor antagonist D-AP5
on CGRP terminals may result from inhibition of spinal LTP.
Because NMDA receptors are also expressed in the presynaptic
terminal and facilitate glutamate release from primary afferents
(Chen et al., 2014; Liu et al., 1994), it is also possible that the acti-
vation of NMDA receptors directly upregulates CGRP expres-
sion and release in the dorsal horn. Further studies are needed
to clarify this issue.
The Roles of Microglia and BDNF in HFS-Induced LTP
and Chronic Pain
Previous work shows that activation of microglia by fractalkine
(CX3CL1), ATP, interleukin-1b (IL-1b), and tumor necrosis factor
alpha (TNF-a) is critical for the induction of spinal LTP (Clark
et al., 2015; Gruber-Schoffnegger et al., 2013; Wang et al.,
2018). In the present study, we further tested the role of microglia
in spinal LTP by depleting resident microglia but not peripheral
monocytes or macrophages using CX3CR1CreER/+:R26iDTR/+
transgenic mice. Our results showed that selective deletion of
spinal microglia blocked HFS-induced LTP, the increase in
CGRP+ terminals, and chronic pain hypersensitivity (Figure 3).
How can HFS activate spinal microglia? A previous study
shows that electrical stimuli (5 Hz, 0.5 ms, 0.1–10 mA, a total
of 3,000 pulses for 10 min) activate spinal glial cell and also
induce nerve degeneration in rats (Shortland et al., 1997). Our
previous study demonstrated that 400 pulses of electrical stim-
ulation at 2 Hz, 20 Hz, or 100 Hz at 30–40 V but not 3 V could
induce spinal LTP in rats (Liu and Sandk€uhler, 1997). In the pre-
sent study, we found that 400-pulse HFS at 10 V (100 Hz, 0.5 ms,
4 trains of 1-s duration at 10-s intervals) was an effective electri-
cal stimulation paradigm in mice for LTP that also leads to spinal
microglia activation and long-lastingmechanical hypersensitivity
without stimulated nerve injury. Collectively, different electrical
stimulating parameters (such as intensity, frequency, and dura-
tion) have different influences on microglial activation. In addi-
tion, previous studies showed that microglial activation induced
by electrical stimulation of the sciatic nerve at C-fiber intensities
can be blocked by the NK1 receptor antagonist LY303870
(Li et al., 2015). Direct activation of glial cells by local application
of BDNF (Zhou et al., 2011), CASP6 (Berta et al., 2014), fractal-
kine (Clark et al., 2015), TNF, or ATP receptor agonists (Kronschl-
a¨ger et al., 2016) is sufficient to induce spinal LTP and pain
hypersensitivity through microglia without causing axonal
degeneration. Therefore, spinal microglia are able to sense noci-
ceptive signals, and the neuromodulators (such as SP, ATP,
Figure 7. The Mechanism of HFS of Sciatic Nerve-Induced Chronic
Pain without Stimulated Sciatic Nerve Injury
HFS of the sciatic nerve depolarizes DRG neurons to release CSF1 from the
central terminals. CSF1 activates microglial CSF1R/p38 MAPK to release
BDNF. BDNF causes an increase in CGRP terminals via TrkB/CREB signaling.
Microglia activation and the CGRP terminal increase underlie prolonged LTP
and chronic pain.
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BDNF, CASP6, or CSF1) released from peptidergic C-fibers are
essential for rapid microglial activation.
Previous work (Guan et al., 2016) showed that CSF1 is upregu-
lated in injured DRG neurons 1 day but not 12 h after peripheral
nerve injury. CSF1Rs, which are exclusively expressed in micro-
glia in the SDH, are upregulated 2–3 days after nerve injury. CSF1
in injured DRG neurons is suggested to transport to the SDH,
where it activates microglia by binding to CSF1Rs. In the present
work, we found that 10 V HFS also upregulated CSF1mRNA and
protein in DRG neurons, although the magnitude of the upregu-
lation was weaker than that induced by SNI (Figures 5A, 5B, and
5D). Importantly, HFS upregulates CSF1 only in CGRP+ terminals
in the SDH (Figure 5C). HFS also upregulated CSF1R in spinal
microglia. Our results showed that HFS-induced LTP and pain
hypersensitivity occurred swiftly (within hours), whereas CGRP
was upregulated days after HFS (Figure 2). These results sug-
gest that HFS-induced LTP might be the trigger for later
biochemical changes in the SDH. In terms of Iba1 upregulation
3 days after HFS (Figure 3), this may reflect late activation of
microglia. HFS may acutely activate microglia through CSF1
signaling within hours, when Iba1 upregulation did not yet
happen. We propose that spinal microglia are activated by neu-
rotransmitters released from CGRP+ C-termini immediately after
HFS and later by CSF1, which is increased in CGRP+ terminals.
Therefore, CGRP+ C-termini are critically involved in the initiation
and maintenance of microglial activation in SDH.
It is well established that activation of the BDNF/TrkB pathway
is essential for both spinal LTP induction (Zhou et al., 2008) and
the development of neuropathic pain (Coull et al., 2005). BDNF
expressed in peptidergic DRG neurons is released from central
terminals in the SDH in response to short bursts of HFS at C-fiber
strength (300 pulses in 75 trains, 100 Hz) along with SP and
glutamate (Lever et al., 2001). Selective deletion of BDNF in noci-
ceptive DRG neurons impairs the inflammatory pain induced by
formalin or carrageenan injection; however, it does not affect
neuropathic pain (Zhao et al., 2006). Consistent with previous
work (Sorge et al., 2015), we found that genetic depletion of
BDNF from microglia attenuates nerve injury-induced mechani-
cal allodynia in male but not in female mice (Figure 4E). However,
microglial BDNF deletion prevents HFS-induced LTP, CGRP up-
regulation, and mechanical allodynia in both male and female
mice (Figure 4E). Our data confirmed that BDNF was sufficient
to enhance CGRP+ terminals in vivo and in vitro. Previous work
showed TrkB expression in CGRP peptidergic C-fiber terminals
(Merighi et al., 2008). We further uncovered that the BDNF/TrkB/
CREB signaling pathway is involved in CGRP terminal increase.
Although our results indicate an important role of microglial
BDNF in chronic pain induced by nerve injury and HFS, recent
studies show that BDNF gene expression is at very low levels
in microglia of the adult brain (Bennett et al., 2016) and spinal
cord (Denk et al., 2016). Therefore, BDNF released from micro-
glia might be limited. How the small amount of BDNF is so
important for chronic pain remains elusive. In addition, it is still
unknown how BDNF from diverse sources (nociceptive afferents
versus microglia) differentially affects inflammatory pain and
neuropathic pain and why deletion of microglial BDNF attenu-
ates neuropathic pain only in male mice but suppresses HFS-
induced chronic pain in both male and female mice. We believe
that the discrepancy could be due to the different pain models;
i.e., HFS-induced chronic pain versus nerve injury-induced
neuropathic pain. Further studies are needed to clarify these is-
sues. Interestingly, our previous study showed that inhibition of
BDNF signaling did not affect LTP induced by 40 V HFS in rats
(Zhou et al., 2008). The discrepancy could be due to the potential
damage to the stimulated nerve by 40 V HFS, as reported previ-
ously (Liang et al., 2010). Therefore, both nerve injury and activa-
tion of afferent fibers contribute to HFS-induced LTP, likely using
different signaling pathways.
In summary, we report that the electrical HFS that induces
spinal LTP at C-fiber synapses without causing injury of the stim-
ulated nerve leads to long-lasting mechanical allodynia and
thermal hyperalgesia in mice. Our findings may explain chronic
primary pain that occurs in the absence of injury or disease.
STAR+METHODS
Detailed methods are provided in the online version of this paper
and include the following:
d KEY RESOURCES TABLE
d CONTACT FOR REAGENT AND RESOURCE SHARING
d EXPERIMENTAL MODEL AND SUBJECT DETAILS
B Animals and husbandry
B Electrical stimulation-induced chronic pain model
B Spared nerve injury
d METHOD DETAILS
B Microglia ablation and repopulation
B Microglial BDNF deletion
B In vivo extracellular recordings in the dorsal horn
B Behavioral tests
B Local application of lidocaine around the sciatic nerve
B Intrathecal injection of drugs
B Fluorescent immunohistochemical staining
B Western blot
B Ultrastructure of rat sciatic nerves
B Pre-embedding immunoelectron microscopy (IEM)
B qRT-PCR
B Culture of DRG neurons
B Acute spinal cord slice culture
d QUANTIFICATION AND STATISTICAL ANALYSIS
B Statistical analysis
B Quantification of immunofluorescence staining
B TEM analysis
B IEM analysis
B Analysis of CGRP neurite length
SUPPLEMENTAL INFORMATION
Supplemental Information can be found online at https://doi.org/10.1016/j.
celrep.2019.05.087.
ACKNOWLEDGMENTS
This work was supported by the National Institutes of Health, United States
(R21DE025689 and R01NS088627), the National Natural Science Foundation
of China (81771204, U1201223, 8137119, and 81270377), the Guangdong Prov-
ince University Outstanding Young Teachers’ Training Program (Yq2013008),
Cell Reports 27, 3844–3859, June 25, 2019 3857
and the Natural Science Foundation of Guangdong Province, China
(S2013010011889 and 2014A030313062). We thank Dr. Wen-Biao Gan (New
York University) for providing CX3CR1CreER/+ mice and Noriko Goldsmith
(Rutgers University) for technical assistance with confocal microscopy. Also,
we greatly appreciate all members of the Wu lab at Rutgers University and the
Mayo Clinic for insightful discussions.
AUTHOR CONTRIBUTIONS
L.-J.Z., J.R.R., Z.T., X.-G.L., and L.-J.W. conceived the study, designed the
experiments, and wrote the manuscript. L.-J.Z. performed most of the exper-
iments. J.P. and Y.-N.X. performed intrathecal injection of drugs and per-
formed all blind pain behavior tests. L.-J.Z., Y.-N.X., W.-J.Z., and J.Z. per-
formed the spinal culture, DRG neuron culture, and qRT-PCR experiments.
W.-J.Z., Z.T., and T.C. performed the IEM experiments and data analysis.
X.W. performed the experiment in rats. C.-L.M., Z.-J.L., Y.L., M.M., U.B.E.,
A.D.U., W.-J.X., M.L., and H.W. assisted with experiments.
DECLARATION OF INTERESTS
The authors declare no competing interests.
Received: April 19, 2018
Revised: January 29, 2019
Accepted: May 22, 2019
Published: June 25, 2019
REFERENCES
Bangratz, M., Sarrazin, N., Devaux, J., Zambroni, D., Echaniz-Laguna, A.,
Rene´, F., Boe¨rio, D., Davoine, C.S., Fontaine, B., Feltri, M.L., et al. (2012). A
mouse model of Schwartz-Jampel syndrome reveals myelinating Schwann
cell dysfunction with persistent axonal depolarization in vitro and distal periph-
eral nerve hyperexcitability when perlecan is lacking. Am. J. Pathol. 180, 2040–
2055.
Bennett, M.L., Bennett, F.C., Liddelow, S.A., Ajami, B., Zamanian, J.L., Fernh-
off, N.B., Mulinyawe, S.B., Bohlen, C.J., Adil, A., Tucker, A., et al. (2016). New
tools for studying microglia in the mouse and human CNS. Proc. Natl. Acad.
Sci. USA 113, E1738–E1746.
Benowitz, L.I., and Routtenberg, A. (1997). GAP-43: an intrinsic determinant of
neuronal development and plasticity. Trends Neurosci. 20, 84–91.
Berta, T., Park, C.K., Xu, Z.Z., Xie, R.G., Liu, T., L€u, N., Liu, Y.C., and Ji, R.R.
(2014). Extracellular caspase-6 drives murine inflammatory pain via microglial
TNF-a secretion. J. Clin. Invest. 124, 1173–1186.
Bliss, T.V., and Collingridge, G.L. (1993). A synaptic model of memory: long-
term potentiation in the hippocampus. Nature 361, 31–39.
Borroto-Escuela, D.O., Agnati, L.F., Bechter, K., Jansson, A., Tarakanov, A.O.,
and Fuxe, K. (2015). The role of transmitter diffusion and flow versus extracel-
lular vesicles in volume transmission in the brain neural-glial networks. Philos.
Trans. R. Soc. Lond. B Biol. Sci. 370, 20140183.
Chen, S.R., Hu, Y.M., Chen, H., and Pan, H.L. (2014). Calcineurin inhibitor
induces pain hypersensitivity by potentiating pre- and postsynaptic NMDA
receptor activity in spinal cords. J. Physiol. 592, 215–227.
Chen, L.H., Sun, Y.T., Chen, Y.F., Lee, M.Y., Chang, L.Y., Chang, J.Y., and
Shen, M.R. (2015). Integrating Image-Based High-Content Screening with
Mouse Models Identifies 5-Hydroxydecanoate as a Neuroprotective Drug for
Paclitaxel-Induced Neuropathy. Mol. Cancer Ther. 14, 2206–2214.
Christensen, M.D., and Hulsebosch, C.E. (1997). Spinal cord injury and anti-
NGF treatment results in changes in CGRP density and distribution in the
dorsal horn in the rat. Exp. Neurol. 147, 463–475.
Clark, A.K., Gruber-Schoffnegger, D., Drdla-Schutting, R., Gerhold, K.J., Mal-
cangio, M., and Sandk€uhler, J. (2015). Selective activation of microglia facili-
tates synaptic strength. J. Neurosci. 35, 4552–4570.
Coull, J.A., Beggs, S., Boudreau, D., Boivin, D., Tsuda, M., Inoue, K., Gravel,
C., Salter, M.W., and De Koninck, Y. (2005). BDNF from microglia causes
the shift in neuronal anion gradient underlying neuropathic pain. Nature 438,
1017–1021.
Csa´ti, A., Edvinsson, L., Ve´csei, L., Toldi, J., F€ulo¨p, F., Tajti, J., and Warfvinge,
K. (2015). Kynurenic acid modulates experimentally induced inflammation in
the trigeminal ganglion. J. Headache Pain 16, 99.
Decosterd, I., and Woolf, C.J. (2000). Spared nerve injury: an animal model of
persistent peripheral neuropathic pain. Pain 87, 149–158.
Denk, F., Crow, M., Didangelos, A., Lopes, D.M., and McMahon, S.B. (2016).
Persistent Alterations in Microglial Enhancers in a Model of Chronic Pain. Cell
Rep. 15, 1771–1781.
Edvinsson, L., Haanes, K.A., Warfvinge, K., and Krause, D.N. (2018). CGRP as
the target of new migraine therapies - successful translation from bench to
clinic. Nat. Rev. Neurol. 14, 338–350.
Flatters, S.J., and Bennett, G.J. (2006). Studies of peripheral sensory nerves in
paclitaxel-induced painful peripheral neuropathy: evidence for mitochondrial
dysfunction. Pain 122, 245–257.
Gruber-Schoffnegger, D., Drdla-Schutting, R., Ho¨nigsperger, C., Wunderbal-
dinger, G., Gassner, M., and Sandk€uhler, J. (2013). Induction of thermal
hyperalgesia and synaptic long-term potentiation in the spinal cord lamina I
by TNF-a and IL-1b is mediated by glial cells. J. Neurosci. 33, 6540–6551.
Gu, N., Peng, J., Murugan, M., Wang, X., Eyo, U.B., Sun, D., Ren, Y., DiCicco-
Bloom, E., Young,W., Dong, H., andWu, L.J. (2016). Spinal Microgliosis Due to
Resident Microglial Proliferation Is Required for Pain Hypersensitivity after Pe-
ripheral Nerve Injury. Cell Rep. 16, 605–614.
Guan, Z., Kuhn, J.A., Wang, X., Colquitt, B., Solorzano, C., Vaman, S., Guan,
A.K., Evans-Reinsch, Z., Braz, J., Devor, M., et al. (2016). Injured sensory
neuron-derived CSF1 induces microglial proliferation and DAP12-dependent
pain. Nat. Neurosci. 19, 94–101.
Hargreaves, K., Dubner, R., Brown, F., Flores, C., and Joris, J. (1988). A new
and sensitive method for measuring thermal nociception in cutaneous hyper-
algesia. Pain 32, 77–88.
Inoue, K., and Tsuda, M. (2018). Microglia in neuropathic pain: cellular and
molecular mechanisms and therapeutic potential. Nat. Rev. Neurosci. 19,
138–152.
Ji, R.R., and Suter, M.R. (2007). p38 MAPK, microglial signaling, and neuro-
pathic pain. Mol. Pain 3, 33.
Jun, B.K., Chandra, A., Kuljis, D., Schmidt, B.P., and Eichler, F.S. (2015). Sub-
strate Availability of Mutant SPT Alters Neuronal Branching and Growth Cone
Dynamics in Dorsal Root Ganglia. J. Neurosci. 35, 13713–13719.
Kronschla¨ger, M.T., Drdla-Schutting, R., Gassner, M., Honsek, S.D., Teuch-
mann, H.L., and Sandk€uhler, J. (2016). Gliogenic LTP spreads widely in noci-
ceptive pathways. Science 354, 1144–1148.
Lever, I.J., Bradbury, E.J., Cunningham, J.R., Adelson, D.W., Jones, M.G.,
McMahon, S.B., Marvizo´n, J.C., and Malcangio, M. (2001). Brain-derived neu-
rotrophic factor is released in the dorsal horn by distinctive patterns of afferent
fiber stimulation. J. Neurosci. 21, 4469–4477.
Li, W.W., Guo, T.Z., Shi, X., Sun, Y., Wei, T., Clark, D.J., and Kingery, W.S.
(2015). Substance P spinal signaling induces glial activation and nociceptive
sensitization after fracture. Neuroscience 310, 73–90.
Liang, L., Wang, Z., L€u, N., Yang, J., Zhang, Y., and Zhao, Z. (2010). Involve-
ment of nerve injury and activation of peripheral glial cells in tetanic
sciatic stimulation-induced persistent pain in rats. J. Neurosci. Res. 88,
2899–2910.
Liu, X.G., and Sandk€uhler, J. (1995). Long-term potentiation of C-fiber-evoked
potentials in the rat spinal dorsal horn is prevented by spinal N-methyl-D-
aspartic acid receptor blockage. Neurosci. Lett. 191, 43–46.
Liu, X., and Sandk€uhler, J. (1997). Characterization of long-term potentiation of
C-fiber-evoked potentials in spinal dorsal horn of adult rat: essential role of
NK1 and NK2 receptors. J. Neurophysiol. 78, 1973–1982.
Liu, X.G., and Zhou, L.J. (2015). Long-term potentiation at spinal C-fiber syn-
apses: a target for pathological pain. Curr. Pharm. Des. 21, 895–905.
3858 Cell Reports 27, 3844–3859, June 25, 2019
Liu, H., Wang, H., Sheng, M., Jan, L.Y., Jan, Y.N., and Basbaum, A.I. (1994).
Evidence for presynaptic N-methyl-D-aspartate autoreceptors in the spinal
cord dorsal horn. Proc. Natl. Acad. Sci. USA 91, 8383–8387.
Liu, X., Eschenfelder, S., Blenk, K.H., Ja¨nig, W., and Ha¨bler, H. (2000). Spon-
taneous activity of axotomized afferent neurons after L5 spinal nerve injury in
rats. Pain 84, 309–318.
Liu, Y., Zhou, L.J., Wang, J., Li, D., Ren, W.J., Peng, J., Wei, X., Xu, T., Xin,
W.J., Pang, R.P., et al. (2017). TNF-a Differentially Regulates Synaptic Plas-
ticity in the Hippocampus and Spinal Cord by Microglia-Dependent Mecha-
nisms after Peripheral Nerve Injury. J. Neurosci. 37, 871–881.
Lynch, M.A. (2004). Long-term potentiation and memory. Physiol. Rev. 84,
87–136.
Matsuura, Y., Ohtori, S., Iwakura, N., Suzuki, T., Kuniyoshi, K., and Takahashi,
K. (2013). Expression of activating transcription factor 3 (ATF3) in uninjured
dorsal root ganglion neurons in a lower trunk avulsion pain model in rats.
Eur. Spine J. 22, 1794–1799.
Merighi, A., Bardoni, R., Salio, C., Lossi, L., Ferrini, F., Prandini, M., Zonta, M.,
Gustincich, S., and Carmignoto, G. (2008). Presynaptic functional trkB recep-
tors mediate the release of excitatory neurotransmitters from primary afferent
terminals in lamina II (substantia gelatinosa) of postnatal rat spinal cord. Dev.
Neurobiol. 68, 457–475.
Orita, S., Eguchi, Y., Kamoda, H., Arai, G., Ishikawa, T., Miyagi, M., Inoue, G.,
Suzuki, M., Toyone, T., Aoki, Y., et al. (2011). Brain-derived neurotrophic factor
inhibition at the punctured intervertebral disc downregulates the production of
calcitonin gene-related peptide in dorsal root ganglia in rats. Spine 36, 1737–
1743.
Parkhurst, C.N., Yang, G., Ninan, I., Savas, J.N., Yates, J.R., 3rd, Lafaille, J.J.,
Hempstead, B.L., Littman, D.R., and Gan, W.B. (2013). Microglia promote
learning-dependent synapse formation through brain-derived neurotrophic
factor. Cell 155, 1596–1609.
Peng, J., Gu, N., Zhou, L., B Eyo, U., Murugan, M., Gan, W.B., and Wu, L.J.
(2016). Microglia and monocytes synergistically promote the transition from
acute to chronic pain after nerve injury. Nat. Commun. 7, 12029.
Pfau, D.B., Klein, T., Putzer, D., Pogatzki-Zahn, E.M., Treede, R.D., and Ma-
gerl, W. (2011). Analysis of hyperalgesia time courses in humans after painful
electrical high-frequency stimulation identifies a possible transition from early
to late LTP-like pain plasticity. Pain 152, 1532–1539.
Saeed, A.W., and Ribeiro-da-Silva, A. (2012). Non-peptidergic primary affer-
ents are presynaptic to neurokinin-1 receptor immunoreactive lamina I projec-
tion neurons in rat spinal cord. Mol. Pain 8, 64.
Sandk€uhler, J., and Gruber-Schoffnegger, D. (2012). Hyperalgesia by synaptic
long-term potentiation (LTP): an update. Curr. Opin. Pharmacol. 12, 18–27.
Seltzer, Z., Cohn, S., Ginzburg, R., and Beilin, B. (1991). Modulation of neuro-
pathic pain behavior in rats by spinal disinhibition and NMDA receptor
blockade of injury discharge. Pain 45, 69–75.
Shortland, P., Kinman, E., and Molander, C. (1997). Sprouting of A-fibre pri-
mary afferents into lamina II in two rat models of neuropathic pain. Eur. J.
Pain 1, 215–227.
Song, X.Y., Li, F., Zhang, F.H., Zhong, J.H., and Zhou, X.F. (2008). Peripherally-
derived BDNF promotes regeneration of ascending sensory neurons after
spinal cord injury. PLoS ONE 3, e1707.
Sorge, R.E., Mapplebeck, J.C., Rosen, S., Beggs, S., Taves, S., Alexander,
J.K., Martin, L.J., Austin, J.S., Sotocinal, S.G., Chen, D., et al. (2015). Different
immune cells mediate mechanical pain hypersensitivity in male and female
mice. Nat. Neurosci. 18, 1081–1083.
Sturge, W.A. (1883). The Phenomen of Angina Pectoris, and Their Bearing
Upon The theory of Counter-Irritation. Brain 5, 492–510.
Treede, R.D., Rief, W., Barke, A., Aziz, Q., Bennett, M.I., Benoliel, R., Cohen,
M., Evers, S., Finnerup, N.B., First, M.B., et al. (2015). A classification of
chronic pain for ICD-11. Pain 156, 1003–1007.
Wang, Z.C., Li, L.H., Bian, C., Yang, L., Lv, N., and Zhang, Y.Q. (2018). Involve-
ment of NF-kB and the CX3CR1 signaling network in mechanical allodynia
induced by tetanic sciatic stimulation. Neurosci. Bull. 34, 64–73.
Wong, H., Kang, I., Dong, X.D., Christidis, N., Ernberg, M., Svensson, P., and
Cairns, B.E. (2014). NGF-induced mechanical sensitization of the masseter
muscle is mediated through peripheral NMDA receptors. Neuroscience 269,
232–244.
Xu, T., Li, D., Zhou, X., Ouyang, H.D., Zhou, L.J., Zhou, H., Zhang, H.M., Wei,
X.H., Liu, G., and Liu, X.G. (2017). Oral Application of Magnesium-L-Threonate
Attenuates Vincristine-induced Allodynia and Hyperalgesia by Normalization
of Tumor Necrosis Factor-a/Nuclear Factor-kB Signaling. Anesthesiology
126, 1151–1168.
Yekkirala, A.S., Roberson, D.P., Bean, B.P., and Woolf, C.J. (2017). Breaking
barriers to novel analgesic drug development. Nat. Rev. Drug Discov. 16,
545–564.
Zhang, H.M., Zhou, L.J., Hu, X.D., Hu, N.W., Zhang, T., and Liu, X.G.
(2004). Acute nerve injury induces long-term potentiation of C-fiber evoked
field potentials in spinal dorsal horn of intact rat. Sheng Li Xue Bao 56,
591–596.
Zhao, J., Seereeram, A., Nassar, M.A., Levato, A., Pezet, S., Hathaway, G.,
Morenilla-Palao, C., Stirling, C., Fitzgerald, M., McMahon, S.B., et al.; London
Pain Consortium (2006). Nociceptor-derived brain-derived neurotrophic factor
regulates acute and inflammatory but not neuropathic pain. Mol. Cell. Neuro-
sci. 31, 539–548.
Zheng, L.F., Wang, R., Xu, Y.Z., Yi, X.N., Zhang, J.W., and Zeng, Z.C. (2008).
Calcitonin gene-related peptide dynamics in rat dorsal root ganglia and spinal
cord following different sciatic nerve injuries. Brain Res. 1187, 20–32.
Zhong, Y., Zhou, L.J., Ren, W.J., Xin, W.J., Li, Y.Y., Zhang, T., and Liu, X.G.
(2010). The direction of synaptic plasticitymediated by C-fibers in spinal dorsal
horn is decided by Src-family kinases in microglia: the role of tumor necrosis
factor-alpha. Brain Behav. Immun. 24, 874–880.
Zhou, L.J., Zhong, Y., Ren,W.J., Li, Y.Y., Zhang, T., and Liu, X.G. (2008). BDNF
induces late-phase LTP of C-fiber evoked field potentials in rat spinal dorsal
horn. Exp. Neurol. 212, 507–514.
Zhou, L.J., Yang, T., Wei, X., Liu, Y., Xin, W.J., Chen, Y., Pang, R.P., Zang, Y.,
Li, Y.Y., and Liu, X.G. (2011). Brain-derived neurotrophic factor contributes to
spinal long-term potentiation and mechanical hypersensitivity by activation of
spinal microglia in rat. Brain Behav. Immun. 25, 322–334.
Zhuo, M., Wu, G., andWu, L.J. (2011). Neuronal and microglial mechanisms of
neuropathic pain. Mol. Brain 4, 31.
Cell Reports 27, 3844–3859, June 25, 2019 3859
STAR+METHODS
KEY RESOURCES TABLE
REAGENT or RESOURCE SOURCE IDENTIFIER
Antibodies
Rabbit anti-ATF3 Santa Cruz Biotechnology Cat# sc-188 RRID:AB_2258513
Goat anti-Iba1 Abcam Cat# ab5076 RRID:AB_2224402
Rat anti-NIMP-R14 Santa Cruz Biotechnology Cat# sc-59338 RRID: AB_2167795
Goat anti-CGRP Abcam Cat# 36001 RRID: AB_725807
Mouse anti-CGRP Abcam Cat# ab81887 RRID: AB_1658411
Isolectin B4-FITC Sigma Cat# L2895
Rabbit anti-Synaptophysin Abcam Cat# ab16659 RRID: AB_443419
Rabbit anti-GAP43 Abcam Cat# ab128005 RRID:AB_11141048
Rabbit anti-Substance P receptor EMD Millipore Cat# AB5060 RRID:AB_2200636
Goat anti-CSF1 R&D Systems Cat# AF416 RRID:AB_355351
Goat IgG R&D Systerms Cat# AB-108-C RRID:AB_354267
Rabbit anti-CSF1R Santa Cruz Biotechnology Cat# sc-692 RRID:AB_631025
Rat anti-CD11b Biolegend Cat# 101202 RRID:AB_312785
Rabbit anti-BDNF Millipore Cat# AB1534 RRID:AB_90746
Rabbit anti- phospho-p38 Cell Signaling Technology Cat# 4511 RRID:AB_2139682
Mouse anti-b-actin Cell Signaling Technology Cat# 3700 RRID:AB_2242334
Chemicals, Peptides, and Recombinant Proteins
D-AP5 Tocris Cat# 0106
Lidocaine Sigma Cat# L7757
Collagenase Sigma Cat# C9891
Trypsin Sigma Cat# T9201
Poly-L-Lysine Sigma Cat# P4832
Glutamine Sigma Cat# G7513
ANA-12 Tocris Cat# 4781
666-15 Tocris Cat# 5661
SB203580 Tocris Cat# 1202
CSF1 Biolegend Cat# 576402
BDNF R&D Systems Cat# 248-BD
Tamoxifen Sigma Cat# T5648
Diphtheria toxin Sigma Cat# C8286
Urethane Sigma Cat# U2500
Lidocaine Sigma Cat# L7757
Fluoromount-G Southern Biotech Cat# 0100-01
Experimental Models: Organisms/Strains
C57BL/6J Jackson Laboratories Cat# JAX:000664 RRID:IMSR_JAX:000664
CX3CR1CreER/+ mice Parkhurst et al., 2013 Cat# JAX:021160, RRID:IMSR_JAX:021160
BDNFflox/flox(BDNFTM3JAE/J) Jackson Laboratories Cat# JAX:004339, RRID:IMSR_JAX:004339
R26iDTR/+ mice Jackson Laboratories Cat# JAX:007900, RRID:IMSR_JAX:007900
Sprague–Dawley rats Charles River Laboratory Cat# 10395233, RRID:RGD_10395233
Oligonucleotides
Csf1 Forward: GTGTCAGAACACTGTAGCCAC Thermo Fisher Scientific N/A
Csf1 Reverse: TCAAAGGCAATCTGGCATGAAG Thermo Fisher Scientific N/A
b-actin Forward: CCACACCCGCCACCAGTTCG Thermo Fisher Scientific N/A
(Continued on next page)
e1 Cell Reports 27, 3844–3859.e1–e6, June 25, 2019
CONTACT FOR REAGENT AND RESOURCE SHARING
Further information and requests for reagents may be directed to and will be fulfilled by the lead contact author, Long-Jun Wu
(wu.longjun@mayo.edu).
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Animals and husbandry
Young adult (8-12 weeks old) C57BL/6 (Charles River) mice were used as wild-type controls. In some experiments, Sprague–Dawley
rats (210–280 g, Laboratory animal center, Sun Yat-sen University, Guangzhou) were used. CX3CR1CreER/+ mice (gifted from Dr.Wen-
Biao Gan at New York University) were crossed with R26iDTR/+ (Jackson Laboratory) to obtain CX3CR1CreER/+:R26iDTR/+ mice.
CX3CR1CreER/+ mice were crossed with BDNFflox/flox (BDNFTM3JAE/J, Jackson Laboratory) to obtain CX3CR1CreER/+:BDNFflox/flox
mice. Most experiments were performed with adult male mice, and only in one special experiment of sex differences, male and female
mice was used, which was specially indicated. The rodents were housed in a standard 12 h light/dark cycle (lights on 06:00) and tem-
perature (23 ± 2C) controlled room with access to food and water ad libitum. All experimental protocols and animal handling proced-
ures were approved by the institutional animal care and use committee at Rutgers University (USA) or Sun Yat-sen University (China).
Electrical stimulation-induced chronic pain model
Rodent were anesthetized with 2% isoflurane anesthesia and the left sciatic nerves were dissected free for electrical stimulation with
bipolar platinum hook electrodes. HFS at different intensities (1, 10, 20 V) was delivered to the left sciatic nerve. In the shamgroup, the
sciatic nervewas exposed and the electrodewas laid asidewithout electrical stimulation. At the end, themuscle and skin were closed
in two layers. Following surgery, mice were allowed to awake from anesthesia and were fully mobile before being returned to their
home cage. The surgery was always performed in littermates and housed together until further experimentation.
Spared nerve injury
Spared nerve injury (SNI) surgery was performed as previously described (Decosterd and Woolf, 2000). Under 2% isoflurane anes-
thesia, incisionwasmade along themid-line of the left hind limb. The common peroneal and the tibial nerveswere then ligated and cut
(2 mm sections removed), but the sural nerve was left intact. At the end, the wound was sutured in two layers.
METHOD DETAILS
Microglia ablation and repopulation
According to themethod described in our recent study (Peng et al., 2016), CX3CR1CreER/+ (Control) mice or CX3CR1CreER/+:R26iDTR/+
mice (over 6 weeks old) were intraperitoneally (i.p.) given tamoxifen (TM, Sigma, T5648, 0.15 g/kg, 20 mg/ml in corn oil with
Continued
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ultrasound) every other day for 4 times. Then two doses of diphtheria toxin (DT, Sigma, C8286, 50 mg/kg, 2.5 mg/ml in PBS) or vehicle
(corn oil) were i.p. injected 3 weeks later to induce microglial ablation. To test the role of microglial ablation or repopulation or the
effect of TM only, HFS-induced synaptic plasticity and chronic pain, HFS was delivered to the sciatic nerve on the 3rd or 21st day
after the first DT injection, or the 7th day before the first DT injection, respectively. The effectiveness of microglial ablation or repo-
pulation was tested at these time points by performing immunostaining of Iba1 in the spinal cord tissue.
Microglial BDNF deletion
CX3CR1CreER/+:BDNFflox/flox mice were i.p. treated with TM (0.15 g/kg, 20mg/ml) or vehicle (corn oil) 3 times every other day and then
kept for more than 3 weeks to be used as microglial BDNF ablation (BDNF/) mice. The mice without injection of TM served as
control group (BDNF+/+).
In vivo extracellular recordings in the dorsal horn
Protocols for surgical preparation and in vivo extracellular recordings of the C-fiber-induced field potential have been described
in our previous studies (Liu and Sandk€uhler, 1995; Zhong et al., 2010). Briefly, animals were anesthetized with urethane (Sigma,
1.5 g/kg, i.p.). A laminectomy was performed to expose the lumbar enlargement of the spinal cord. The left sciatic nerve was gently
dissected free for electrical stimulation with a bipolar platinum hook electrode. Then the animal were placed in a stereotaxic frame
and a small well with gel seal was formed on the cord dorsum at the recording segments for drug application or warm paraffin oil.
The dura mater was incised longitudinally. Then, test stimuli (0.5 ms duration, every 1 min, at C-fiber intensity) was delivered to the
sciatic nerve. C-fiber evoked fEPSPwas recorded from the dorsal horn of mouse spinal cord with a glassmicroelectrode (filled with
0.5 M sodium acetate, impedance 0.5–1 MU). The optimal recording position for C-fiber fEPSP was at a depth of around
200–350 mm from the surface of the L4 lumbar enlargement of the spinal cord formice. An A/D converter card (National Instruments
M-Series PCI express) was used to digitize and store data at a sampling rate of 10 kHz in a computer. fEPSP was at a depth of
around 2 of C-fiber evoked fEPSP was determined on-line by LTP program (https://www.winltp.com/). In each experiment, am-
plitudes of five consecutive fEPSP recorded at 1 min intervals was averaged. The mean amplitudes of the responses before
0.1 M PBS/saline or drug application served as baseline. Different intensities (1, 10, 20 V) of high-frequency stimulation (HFS:
100 Hz, 0.5 ms, 100 pulses given in 4 trains of 1 s duration at 10 s intervals) were used as conditional stimulation in left sciatic nerve
to induce LTP of C-fiber evoked fEPSP. In some experiments to observe the effects of the drugs on C-fiber evoked field potentials,
goat anti-CSF1 antibody (AF416, 40.0 ng/ml, 20 ml, R&D Systerms, USA) or normal goat IgG control (AB-108-C, 40.0 ng/ml,
R&D Systerms, USA) was directly administered onto the spinal dorsal surface at the recording segments 30 min after stable
recording of C-fiber evoked field potentials. Only one experiment was performed in each animal. At the end of the experiment,
the animals were decapitated under anesthesia.
Behavioral tests
Mechanical Test
Each mouse/rat was acclimated to the test environment and the experimenter 3 days prior to HFS and sham operation and
was again allowed to acclimate for about 30 min before the behavioral test. All the tests were performed by two experimenters,
one blinded to drug and/or surgery treatments. To test mechanical allodynia, animals were placed on an elevated wire grid
and the plantar surface of the paw was stimulated with a set of Von Frey filaments (0.04 – 2 g for mice and 0.4 – 25 g for
rats; North Coast medical). Each filament was applied from underneath the metal mesh floor to the lateral and medial plantar
surface of the paw. The positive response of mechanical allodynia was considered to be a brisk filament evoked withdrawal
response for up to 3 s to at least one of five repetitive stimuli. 50% paw withdrawal threshold (PWT) was determined using
the up-down method. Mice with pre- surgery/treatment basal mechanical response threshold equal to or less than 0.16 g
were excluded for use.
Thermal Test
Thermal hypersensitivity was measured using a plantar test (7370, UgoBasile, Comeria, Italy) according to the method described by
Hargreaves et al. (1988). The center plantar surface of the hind paw was exposed to a beam of radiant heat through a transparent
Perspex surface. The paw withdrawal latency (PWL) was recorded when a withdrawal response to the radiant heat was observed.
The basal PWL of normal adult C57BL/6J mice was 9-12 s, with a cutoff of 20 s to prevent tissue damage. The heat stimulation was
repeated 4 times at an interval of 5-6 min for each paw and the mean calculated.
Rotarod test
The rotarod tests were performed as an index of injury-inducedmotor deficits by a five-lane Rotarod apparatus (Med Associates Inc).
The rotarod speed started from 4 rounds per minute (RPM) and uniformly accelerated to 40 RPM in 5 minutes. Only the latency to fall
off the rotating rod was recorded. Each mouse was tested for 3 trials with 15 min interval. There is no training prior to the test phase.
Local application of lidocaine around the sciatic nerve
Two percent lidocaine (L7757, 50 ml, Sigma) was administered around the stimulated sciatic nerve 15 min before HFS to block noci-
ceptive nerve transmission via inhibition of sodium channels.
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Intrathecal injection of drugs
Adult male mice (20–30 g) were anesthetized with 1.5% isoflurane and injected intrathecally with different drugs in a volume of 5.0 mL
with a luer-tipped Hamilton syringe at the level of the pelvic girdle. The drugs included goat anti-CSF1 antibody (AF416, 40.0 ng/ml,
R&D Systerms, USA), normal goat IgG control (AB-108-C, 40.0 ng/ml, R&D Systerms, USA), recombinant mouse CSF1 (576402,
6 ng/ml, Biolegend), recombinant mouse BDNF (248-BD, 20 ng/ml, R&D systems), D-AP5 (0106, 50 mg/ml, Tocris) or vehicle (0.1 M
PBS).
Fluorescent immunohistochemical staining
After mice were anesthetized with isoflurane (5% in O2), they were perfused intracardially with 20 mL PBS followed by 20 mL of cold
4%paraformaldehyde (PFA) in PBS (pH 7.4) containing 1.5%picric acid. The electrical stimulated site of the ipsilateral sciatic nerve in
HFS group or the proximal stump of sciatic nerve in SNI group before entering the popliteal fossa were used for studying nerve
damage. L4 dorsal root ganglion (L4 DRG) and L3–L5 segments of spinal cord were harvested and post-fixed in the same fixative
for 4–6 hours, then replaced with 30% sucrose in PBS overnight at 4C. All the tissues were sliced into 15 mm sections using a
cryotome (Leica CM1250, Germany) and transferred on to Superfrost Plus Microscope slides (Fisherbrand).
For cultured spinal slice immunostaining, the slices were fixed with 4% PFA (Sigma) for 30 mins and then washed in Tris-buffered
saline (TBS, pH 7.3) for 3 times with 5-min interval. The tissue sections/cultured DRG neurons were first blocked with 5% donkey
serum in 0.3% Triton X-100 (Sigma) for 60/30 min at room temperature (RT), and then incubated overnight at 4C with a mixture
of rabbit anti-ATF3 (1:500, sc-188, Santa Cruz Biotechnology, USA), mouse anti-CGRP antibody [4901] (1:2000, ab81887, Abcam,
USA), isolectin B4-FITC (1:100, L2895, Sigma, USA), rabbit anti-GAP43 antibody (1:500, ab128005, Abcam, USA), rabbit anti-
Substance P receptor antibody (1:500, AB5060, Millipore, USA.), rabbit anti-Iba1 (1:2000, 019-19741, Wako), goat anti-M-CSF anti-
body (1:500, AF416, R&D Systems, USA); rat anti-CD11b (1:500, 101202, Biolegend, USA); goat anti-Iba1 (1:500, ab5076, Abcam,
USA) or rabbit anti-CSF1R (1:500, sc-692, Santa Cruz Biotechnology, USA). Subsequently, the sections were then incubated with
secondary antibodies (Alexa Fluor 488, 555, 647; Life Technologies) for 60-90 min at RT. The coverslips were mounted with
Fluoromount-G (Southern Biotech) and fluorescent images were obtained with a normal microscope (EVOS FL) (Thermo Fisher
Scientific), and confocal microscopes (LSM510, 780, 800, Zeiss, C2, Nikon). For cultured spinal cord slice, the confocal images
were taken 50 mm thick at depth up 50 mm from the slice surface.
Western blot
Under isoflurane anesthesia, ipsilateral L4-5 spinal dorsal horn tissue was isolated and homogenized with protease inhibitor cocktail
(Roche Molecular Biochemicals) and phosphatase inhibitor. Equal concentration of protein samples were resolved on 4%–12%
NuPAGE Bis-Tris Precast Gels (Thermo Fisher Scientific), and then transferred to PVDF membranes (iBlot 2 Transfer Stacks,
PVDF, regular size (Novex) (Thermo Fisher Scientific). Membranes were blocked and then probed with primary antibodies:
rabbit anti-Iba1 (1:2000, 016-20001, Wako); mouse anti-CGRP antibody [4901] (1:5000, ab81887, Abcam, USA), rabbit anti-
CSF1R (1:1000, sc-692, Santa Cruz Biotechnology, USA), rabbit anti-BDNF (1:1000, AB1534, Millipore, USA), goat anti-M-CSF anti-
body (1:1000, AF416, R&D Systems, USA); rabbit anti-p-p38 (1:2000, #4511, Cell Signaling Technology, USA), mouse anti-b-actin
(1:5000, #3700, Cell Signaling Technology, USA) overnight at 4C. After washed, membranes were then incubated with an HRP-
conjugated secondary antibody (1:50008000, Jackson Immune Laboratory) at RT for 90 min. Protein bands were detected by
ECL detection reagent (34095, Thermo Fisher Scientific) and captured on ImageQuantTMLAS4000 (Fujifilm Life Science). Integrated
optical density was determined using ImageJ 1.48 (NIH). Standard curves were constructed to establish that we operated within the
linear range of the detection method.
Ultrastructure of rat sciatic nerves
After pain behavioral tests at the 7 days after sham, HFS or SNI, the left sciatic nerves of rats (n = 2-3 rats/group, 2 mm distal to the
stimulated or injury point) were obtained and fixed in 4% glutaraldehyde and post-fixed in 1% osmium tetroxide solution at 4 C.
These samples were then dehydrated in graded ethanol series and embedded in Spurr’s resin between two slides coated with di-
methyldichlorosilane (Sigma) in a 37C degree oven for 2 hours and then placed in 60C for 48 hours. The sciatic nerve sections
(70 nm) were prepared, then observed and imaged with Tecnai G2 Spirit Twin electron microscope (FEI, Hillsboro, OR).
Pre-embedding immunoelectron microscopy (IEM)
A total of 5 male C57BL/6J mice (sham: n = 2 mice, HFS 7d: n = 3 mice) at 8-week-old were used. Animals were anesthetized with
7.5%chloral hydrate (1.0 g/kg, i.p.) and perfusedwith 0.1Mphosphate-buffered saline (PBS, pH 7.2) for 1-2min and then followed by
150 mL fixative solution for about 30 min. The fixative solution was consisted of 0.1% glutaraldehyde, 4% paraformaldehyde and
15% saturated picric acid in 0.1 M phosphate buffer (PB, pH 7.2). The lumbar enlargement of spinal cord was harvested and
post-fixed in the same fixative solution but without glutaraldehyde for 3 h at 4C. Spinal transverse sections were cut at a thickness
of 50 mm on a vibratome and then stained using DAB immunohistochemistry method. After washed in PB and rinsed in 25% sucrose
PB solution for 30min, the sections were dipped in liquid nitrogen for 2 s and quickly rinsed in 0.05MTris-buffered saline (TBS, pH 7.2)
for 5 min then incubated in 20% donkey serum in TBS for 30 min. After overnight incubation at 4C with goat anti-CGRP antibodies
(Abcam, 1:150) in 2% donkey serum TBS solution, the spinal sections were then incubated at 4C with biotin labeled donkey
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anti-goat antibodies diluted 1:100 in 2% donkey serum TBS solution overnight. Slices were incubated with HRP-Streptavidin
(PK-6101, Vectorlabs) for 4 hours at room temperature and then treated with diaminobenzidine (DAB, SK-4100, Vectorlabs) and
H2O2. After being rinsed in PB for 5 min three times, the slices were treated with 1% osmic acid in PB, dehydrated in 50% alcohol
and dipped in 1% saturated uranyl acetate (70% alcohol solution) for 40 min. Then the sections were dehydrated in increasing con-
centrations of ethanol and embedded in Spurr’s resin between two slides coated with dimethyldichlorosilane (Sigma) in a 37C de-
gree oven for 2 hours and then placed in 60C for 48 hours. Selected sections were cut and reconstructed with a blade and recut into
serial ultrathin sections. To avoid the effect of densely stained myelinated axons on CGRP immunoreactivity, the sections were not
incubated in lead citrate. These ultrathin sections (70 nm) were collected on 200-mesh copper grids for examination with a Tecnai G2
Spirit Twin electron microscope (FEI, Hillsboro, OR).
qRT-PCR
L4-5 DRGs were excised from each mouse and homogenized in TriZol. RNA was isolated using TriZol/chloroform extraction
and cDNA was prepared from total RNA by reverse transcription reaction with PrimeScript RT Master Mix (RR036A, Takara).
qRT-PCR was performed with CFX 96 touch3 (Bio-rad) using TB Green premix Ex Taq (RR820A, Takara). The conditions for fast
qRT-PCR were as follows: 1 cycle of 95C for 30 s, 40 cycles of 95C for 5 s, and 60C for 30 s. At the end of the PCR, the samples
were subjected to melting analysis to confirm amplicon specificity. Primers sequences are listed as follow: CSF1 Forward
(50-GTGTCAGAACACTGTAGCCAC-30), CSF1 Reverse (50-TCAAAGGCAATCTGGCATGAAG-30); b-actin forward (50-CCACACC
CGCCACCAGTTCG-30), b-actin reverse (50-TACAGCCCGGGGAGCATCGT-30). The relative CSF1 mRNA expression was were
normalized to b-actin in the same group. The ratio of protein/b-actin from sham group were set as 1 baseline. The data from other
groups show the fold with sham baseline.
Culture of DRG neurons
C57BL/6 mice (46wold) were made unconscious by CO2 and then decapitated immediately. After that, the DRGs were bilaterally
dissected out and transferred to DMEM/F12 (GIBCO). After DRGs were digested with 5 mL collagenase (3 mg, C9891 sigma) and
trypsin (2 mg, T9201, sigma) mixture solution for 25 min, and the same volume of complete medium (DMED/F12 + 10% FBS +
1% penicillin and streptomycin 100 3, GIBCO) was added to stop the digestion. Single DRG cells were obtained. These cells
were cultured in 0.01% PLL-coated (Poly-L-Lysine, P4832, sigma) 48well plates in cell culture medium: DMEM/F12 + 10% FBS +
1% penicillin and streptomycin + 1% glutamine (200 mM, G7513, sigma). Four hours later, the supernatant was carefully discarded,
and new culture medium was added. Culture for 4 days and the cell can be treated for following experience: BDNF group contained
50 mg/ml recombinant mouse BDNF (248-BD, R&D systems); ANA-12 group contained 10 or 50 mMANA-12 (a low-molecular weight
TrkB antagonist, Tocris), ANA-12 +CSF1 groupwas culturedwith 10 or 50 mMANA-12 1 h prior to BDNF, 0.5 mM666-15 (a potent and
selective CREB inhibitor, Tocris), 666-15 + CSF1 group was cultured with 0.5 mM 666-15) 1 h prior to BDNF; KCl group contained
40 mM KCl. Then DRG neurons were cultured in humid conditions and 5% CO2 at 37
C. At 24 hours after BDNF, KCl or vehicle
(0.02% DMSO), the culture media were harvested for western blot (WB) to show CSF1 release and the DRG neurons were fixed
for CGRP immunofluorescence.
Acute spinal cord slice culture
The acute spinal cord slice culture was performed following the procedures described previously (Liu et al., 2017). Briefly, normal
46-week-old C57BL/6 mice were anesthetized with 10% urethane (1.5 g/kg, Sigma), then were plunged into 75% alcohol solution
for 30 s. The spines were isolated quickly and put into 4C precooled slice cutting buffer (2.5% 1 M HEPES in EBSS, Sigma). Under
aseptic conditions, the transverse lumbar spinal cord slices were cut at 400 mm thickness with a vibratome (MA752, Campden) and
then transferred onto 0.4 mm culture inserts (PIHP03050, Millipore) which were pre-equilibrated with 1 mL of culture medium. All
culture media contained 50%MEM (GIBCO), 25% EBSS (Sigma), 25% horse serum (GIBCO), 6.5 mg/ml glucose (Sigma), 1% peni-
cillin-streptomycin and 0.05% DMSO (Sigma). CSF1 group contained 1 mg/ml CSF1 (576406, BioLegend); SB203580 (Sigma) group
contained 1 or 10 mM SB203580 (a selective inhibitor of p38 MAPK, Tocris), SB203580 + CSF1 group was cultured with 1 or 10 mM
SB203580 1 h prior to CSF1. The spinal cord slices were cultured in humid conditions and 5% CO2 at 37
C. At 6 hours after CSF1 or
vehicle (0.02% DMSO), the spinal cord slices were collected for immunofluorescence or WB, and the culture media were harvested
for WB to show BDNF release.
QUANTIFICATION AND STATISTICAL ANALYSIS
Statistical analysis
Data were presented as mean ± SEM. Unpaired Student’s t test (2 tailed) were performed after confirming that the groups were nor-
mally distributed with equal variances. Pain behavior tests and electrophysiological data were analyzed by two-way repeated
ANOVA, followed by individual post hoc comparisons (post hoc Tukey’s test or Fisher’s) to establish significance. Other changes
of values of each experimental group were tested using one-way ANOVA, followed by individual post hoc comparisons (post hoc
Tukey’s or Fisher’s test). Statistical significance was calculated using software OriginPro8.0 (OriginLab, USA). Level of significance
is indicated with *or #p < 0.05, ** or ##p < 0.01, *** or ###p < 0.001.
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Quantification of immunofluorescence staining
For the analysis of ATF3 or CGRP-positive cells in the DRGs, the DRG neurons was identified by adjusting brightness/contrast and all
neuronal cells with a clear nuclear profile were counted using the ImageJ image processing and analysis program. 2-4 sections of L4
DRG from each animal were chosen at randomwith the group blinded. The percentage of ATF3 or CGRP-positive neurons in theDRG
neurons was then calculated (Flatters and Bennett, 2006; Matsuura et al., 2013).
Fluorescent signal intensity was also quantified using relative optical density (RelOD) by ImageJ software (National Institutes of
Health, Bethesda, MD). Images used for quantification represent serial optical sections obtained along the z axis (z stacks), using
25X, 40X, 63X plan-apochromatic water-immersion objective. For an unbiased representation of the images taken, all the parameters
of laser power, pinhole size and image detection were kept constant for all samples. Based on Rexed laminae of the spinal cord, the
analysis criteria of CGRP-immunoreactivity (IR) fibers density in the superficial layer is shown in Figure 2C.The criteria of identification
and quantification of the density of CGRP-positive boutons per lamina have been described in previous publications(Saeed and
Ribeiro-da-Silva, 2012). Briefly, the fluorescent CGRP intensity in layer I and IIo, IIi and III & IV was respectively calculated and the
intensity in layer I and IIo fromWT sham tissues or control groupwas set as the 100%baseline. The RelOD of other protein expression
was also measured by the same method. The intensity in L4 DRG from sham tissues or control group was set as the 100% baseline.
The data from each of the other groups were normalized and compared with baseline. Three to five sections permouse from 3-4mice
were randomly selected for each group.
TEM analysis
According to the Erlanger-Gasser Classification, peripheral nerve fibers are grouped based on the diameter of an axon: Aa
(13-20 mm); Ab (6-12 mm); Ad (1-5 mm); C (< 1.5 mm). The diameters of myelinated axons were calculated on the total surface of
the semithin sections of sciatic nerves using the g-ratio calculator plug-in developed for ImageJ software. Axons and nerve fibers
were grouped into increasing size categories separated by 1 mm to calculate their distribution. The G ratios were measured as ratios
of the axon diameter to the fiber diameter in equivalent 26 3 17 mm areas from each nerves previously described (Bangratz et al.,
2012; Chen et al., 2015). Data for this study were collected from total of 4-6 micrographs of sciatic nerve fiber TEM cross-sections
from 2-3 rats/group.
IEM analysis
Lamina II was identified by the paucity of myelinated fibers within the neuropil, which facilitated the determination of the laminae I/II, IIi
and III/IV borders of the dorsal horn of the spinal cord when sections were observed in electronmicroscopes. Data for this study were
collected from a total of 36micrographs (2-3 micrographs/layer/mouse) of cross-sections of well-preserved CGRP+ immunoreactive
elements from five animals. Measurements of labeled structures were made on electron micrograph negatives at 13,500-37,000 3
magnification using a measuring magnifier calibrated in 0.2 mm gradations. Measurements of the number of CGRP positive (CGRP+)
varicosities (Figure 2e, in black circles) or synapses (arrows) in the different layers between sham and HFS 7d groups were made by
two experimenters who were blinded to the treatment.
Analysis of CGRP neurite length
The analyses of CGRP neurite lengths of cultured DRG neurons were determined on ImageJ software following the procedures
described by Jun et al. (2015). The largely overlapped CGRP -positive (CGRP+) neurons were excluded to estimate. Using the
NeuronJ plug-in, all the neurite length of CGRP+ DRG was measured, the average value calculated for 3-4 neurons of each image
(20 X), and the mean neurite length derived from the 4-8 images average values per group (> 15 neurons/group). Neurites were
traced manually from the soma outward, excluding those < 5 mm. All quantitative data were obtained by a blinded experimenter
and normalized to the WT control.
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